Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

EJHaem

Showing results (551-560 of 930) with videos related to

Pageof 93
Sort By:
Ejhaem|July 18, 2022
Thrombotic microangiopathies: First report of 294 cases from a single institution experience in ArgentinaCélia Dos Santos, Juvenal Paiva, María Lucila Romero, et al.
Ejhaem|July 18, 2022
Phase Ib study of avadomide (CC-122) in combination with rituximab in patients with relapsed/refractory diffuse large B-cell lymphoma and follicular lymphomaLoretta J Nastoupil, John Kuruvilla, Julio C Chavez, et al.
Ejhaem|July 18, 2022
The different predictive effects of the intensity and proportion of CD20 expression on the prognosis of B-lineage acute lymphocyte leukemiaYun Tian, Xiaojiao Wang, Hao Ai, et al.
Ejhaem|July 18, 2022
Mast cell density and its clinical relevance in Waldenström's macroglobulinemiaRichard Lemal, Stéphanie Poulain, Albane Ledoux-Pilon, et al.
Ejhaem|July 18, 2022
Secondary hemophagocytic lymphohistiocytosis associated with Rocky Mountain spotted fever in a toddler: A case reportSmitha Hosahalli Vasanna, Peter Paul C Lim, Tanya Saeeda Khan, et al.
Ejhaem|July 18, 2022
A same-day assay predicts apoptotic response to combined BCL-2 and MCL-1 BH3-mimetic targeting in multiple myeloma cellsMartin Grundy, Firas Al-Kaisi, Joanna Cull, et al.
Ejhaem|July 18, 2022
Comparative efficacy and safety of bortezomib, thalidomide, and dexamethasone (VTd) without and with daratumumab (D-VTd) in CASSIOPEIA versus VTd in PETHEMA/GEM in transplant-eligible patients with newly diagnosed multiple myeloma, using propensity score matchingPhilippe Moreau, Cyrille Hulin, Sonja Zweegman, et al.
Ejhaem|July 18, 2022
Corrigendum
Ejhaem|July 18, 2022
Mantle cell lymphoma treatment options for elderly/unfit patients: A systematic reviewTahera Alnassfan, Megan J Cox-Pridmore, Azzam Taktak, et al.
Ejhaem|July 18, 2022
Is it safe and efficacious to remove central lines in pediatric bone marrow transplant patients with platelets less than 20,000/μl?Priya Marwah, Stalin Ramprakash, Sai Prasad T R, et al.
Pageof 93

Showing results (551-560 of 930) with videos related to

Sort By:
Pageof 93
Ejhaem|July 18, 2022
Thrombotic microangiopathies: First report of 294 cases from a single institution experience in ArgentinaCélia Dos Santos, Juvenal Paiva, María Lucila Romero, et al.
Ejhaem|July 18, 2022
Phase Ib study of avadomide (CC-122) in combination with rituximab in patients with relapsed/refractory diffuse large B-cell lymphoma and follicular lymphomaLoretta J Nastoupil, John Kuruvilla, Julio C Chavez, et al.
Ejhaem|July 18, 2022
The different predictive effects of the intensity and proportion of CD20 expression on the prognosis of B-lineage acute lymphocyte leukemiaYun Tian, Xiaojiao Wang, Hao Ai, et al.
Ejhaem|July 18, 2022
Mast cell density and its clinical relevance in Waldenström's macroglobulinemiaRichard Lemal, Stéphanie Poulain, Albane Ledoux-Pilon, et al.
Ejhaem|July 18, 2022
Secondary hemophagocytic lymphohistiocytosis associated with Rocky Mountain spotted fever in a toddler: A case reportSmitha Hosahalli Vasanna, Peter Paul C Lim, Tanya Saeeda Khan, et al.
Ejhaem|July 18, 2022
A same-day assay predicts apoptotic response to combined BCL-2 and MCL-1 BH3-mimetic targeting in multiple myeloma cellsMartin Grundy, Firas Al-Kaisi, Joanna Cull, et al.
Ejhaem|July 18, 2022
Comparative efficacy and safety of bortezomib, thalidomide, and dexamethasone (VTd) without and with daratumumab (D-VTd) in CASSIOPEIA versus VTd in PETHEMA/GEM in transplant-eligible patients with newly diagnosed multiple myeloma, using propensity score matchingPhilippe Moreau, Cyrille Hulin, Sonja Zweegman, et al.
Ejhaem|July 18, 2022
Corrigendum
Ejhaem|July 18, 2022
Mantle cell lymphoma treatment options for elderly/unfit patients: A systematic reviewTahera Alnassfan, Megan J Cox-Pridmore, Azzam Taktak, et al.
Ejhaem|July 18, 2022
Is it safe and efficacious to remove central lines in pediatric bone marrow transplant patients with platelets less than 20,000/μl?Priya Marwah, Stalin Ramprakash, Sai Prasad T R, et al.
Pageof 93